Liabilities / Assets
54th percentile
Higher debt load relative to assets than 54% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
60th percentile
Higher debt load relative to revenue than 60% of similar nonprofits.
Net Margin
48th percentile
Higher net margin than 48% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
50th percentile
Faster asset growth than 50% of similar nonprofits.
Revenue Growth
30th percentile
Faster revenue growth than 30% of similar nonprofits.
Balance Sheet
Assets
Up$135,668
Up $1,327 (+1.0%) from 2019
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Up$1,734
Up $453 (+35%) from 2019
Revenue And Expenses
Revenue
Down$39,690
Down $27,512 (-41%) from 2019
Expenses
Down$38,764
Down $30,335 (-44%) from 2019
Net Income
Up$926
Up $2,823 (+149%) from 2019
Historical Trend
Filing Detail Status
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview
Mission
Providing cancer patients in chemotherapy with kit
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2020 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $135,668
- Liabilities
- $1,734
- Net assets
- -
- Revenue
- $39,690
- Expenses
- $38,764
- Net income
- $926